What sector is ABCL in?

AbCellera Biologics Inc. is classified under GICS Health Care (Biotechnology).

What is ABCL's last close price?

ABCL last closed at $6.16 on 2026-07-16.

ABCL

NASDAQNext earnings·Aug 5AnalystsStrong Buy·8+70%

AbCellera Biologics Inc.

Health Care · Biotechnology

$6.16last close

+51.7%~252d

Price

+51.72% over 1Y

4 auto-fib

Thèse

au 2026-07-16

Antibody-discovery platform - single-cell microfluidics + deep-sequencing + ML to identify and optimize antibody candidates rapidly. Canadian-listed (CAD reporting). Pipeline transition underway: from pure platform-royalty model toward direct internal candidates.

Lead ABCL635 on track for Phase 2 top-line Q3 2026. Cash position CAD 531M + CAD 124M in government funding available.

•2026-Q1 - Cash + marketables CAD 531M (down CAD 30M sequentially); CAD 655M total liquidity including government funding; net loss narrowed slightly Y/Y
•2026 - Interim Phase 1 data for ABCL635 (lead program) showed well-tolerated profile + dose-dependent testosterone suppression; on track for Phase 2 top-line Q3 2026
•2026-1H - Plan to select a 5th internal development candidate; ABCL575 + ABCL688 + ABCL386 progressing through IND-enabling work
•Snapshot 2026-05-18: mcap ~$980M (USD equivalent of CAD listing)
•Setup tension: Multiple shots on goal (5+ programs in clinic by year-end) but Canadian-listed status caps liquidity premium vs US peers; the platform-vs-pipeline transition makes near-term revenue lumpy

clientsEli Lilly · Pfizer · Merck · Government of Canada

Analyze ABCL· interactive tools

Conviction· in 1 watchlist

Top correlated· 252d co-movement

0.61
0.61
0.56
0.54
0.46

Frequently asked questions

What sector is ABCL in?: AbCellera Biologics Inc. is classified under GICS Health Care (Biotechnology).
What is ABCL's last close price?: ABCL last closed at $6.16 on 2026-07-16.